Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Anhydrous Lactose
2. Lactose
3. Lactose, Anhydrous
1. (+)-lactose
2. .beta.-lactose
3. 4-(beta-d-galactosido)-d-glucose
4. 4-o-beta-d-galactopyranosyl-beta-d-glucopyranose
5. 4-o-beta-d-galactopyranosyl-d-glucose
6. Beta-d-glucopyranose, 4-o-beta-d-galactopyranosyl-
7. Beta-d-lactose
8. D-(+)-lactose
9. D-glucose, 4-o-beta-d-galactopyranosyl
10. D-lactose
11. Lactose
12. Lactose [jan]
13. Milk Sugar
14. 5965-66-2
15. Lactose Anhydrous
16. Lactosum Anhydricum
17. Lactobiose
18. Lactin
19. Saccharum Lactin
20. Fast-flo Lactose
21. (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol
22. Aletobiose
23. Galactinum
24. Tablettose
25. Chebi:36218
26. Zeparox Ep
27. Lactose Fast-flo
28. Beta-d-lactose, With 30% Alfa
29. Pharmatose 21
30. 13q3a43e0s
31. Beta-d-galactopyranosyl-(1->4)-beta-d-glucopyranose
32. Lactin (carbohydrate)
33. Osmolactan
34. (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl]oxy-tetrahydropyran-3,4,5-triol
35. Anhydrous Lactose
36. Super-tab
37. Tablettose 70
38. Tablettose 80
39. Pharmatose 325m
40. .beta.-d-lactose
41. Sorbalac 400
42. Flowlac 100
43. Pharmatosa Dcl 21
44. Lat
45. Einecs 227-751-9
46. Unii-13q3a43e0s
47. Saccharum Lactis
48. Beta -lactose
49. 1gwv
50. 1gzc
51. 2zgm
52. Galbeta1-4glcbeta
53. Lactose-electricitas
54. Lactosum, Anhydrous
55. Galb1-4glcb
56. Lactose (8ci)
57. 1ax1
58. 1z3v
59. 2nn8
60. Lactose, Unspecified Form
61. Dsstox_cid_3193
62. Dsstox_rid_76916
63. Dsstox_gsid_23193
64. Chembl417016
65. Dtxsid2023193
66. Dtxsid5058723
67. Zinc4095761
68. Tox21_301866
69. Bdbm50370453
70. Beta-d-galp-(1->4)-beta-d-glcp
71. Akos015950662
72. B-lactose - Min 70% B-anomer
73. Cas-63-42-3
74. Ncgc00255383-01
75. .beta.-d-gal-(1-->4)-.beta.-d-glc
76. Cs-0206827
77. C01970
78. D-glucose, 4-o-b-d-galactopyranosyl- (9ci)
79. F71297
80. Beta-d-galactopyranosyl-(1->4)-beta-d-glucose
81. A832404
82. Q127900
83. 4-o-(beta-d-galactopyranosyl)-beta-d-glucopyranose
84. Beta-lactose, Suitable For Component For Culture Media
85. Beta-d-lactose, Contains Ca. 70% Beta And Ca. 30% Alpha
86. 60b85732-763b-4e21-bd67-6163315fd251
87. Beta-lactose, <=30% Alpha-anomer Basis, >=99% Total Lactose Basis
88. Wurcs=2.0/2,2,1/[a2122h-1b_1-5][a2112h-1b_1-5]/1-2/a4-b1
89. (2r,3r,4r,5s,6r)-6-(hydroxymethyl)-5-(((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2,3,4-triol
90. (2r,3r,4r,5s,6r)-6-(hydroxymethyl)-5-((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)tetrahydro-2h-pyran-2,3,4-triol
91. (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-{[(2r,3s,4r,5r,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol
| Molecular Weight | 342.30 g/mol |
|---|---|
| Molecular Formula | C12H22O11 |
| XLogP3 | -4.7 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 4 |
| Exact Mass | 342.11621151 g/mol |
| Monoisotopic Mass | 342.11621151 g/mol |
| Topological Polar Surface Area | 190 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 382 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Sweetening Agents
Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)
API SUPPLIERS
Certificate Number : R1-CEP 2000-371 - Rev 04
Issue Date : 2013-09-03
Type : TSE
Substance Number :
Status : Valid
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Lactose API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lactose API, including repackagers and relabelers. The FDA regulates Lactose API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lactose API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lactose API supplier is an individual or a company that provides Lactose API active pharmaceutical ingredient (API) or Lactose API finished formulations upon request. The Lactose API suppliers may include Lactose API API manufacturers, exporters, distributors and traders.
click here to find a list of Lactose API suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lactose API CEP of the European Pharmacopoeia monograph is often referred to as a Lactose API Certificate of Suitability (COS). The purpose of a Lactose API CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Lactose API EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Lactose API to their clients by showing that a Lactose API CEP has been issued for it. The manufacturer submits a Lactose API CEP (COS) as part of the market authorization procedure, and it takes on the role of a Lactose API CEP holder for the record. Additionally, the data presented in the Lactose API CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Lactose API DMF.
A Lactose API CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Lactose API CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Lactose API suppliers with CEP (COS) on PharmaCompass.
Lactose API Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lactose API GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lactose API GMP manufacturer or Lactose API GMP API supplier for your needs.
A Lactose API CoA (Certificate of Analysis) is a formal document that attests to Lactose API's compliance with Lactose API specifications and serves as a tool for batch-level quality control.
Lactose API CoA mostly includes findings from lab analyses of a specific batch. For each Lactose API CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lactose API may be tested according to a variety of international standards, such as European Pharmacopoeia (Lactose API EP), Lactose API JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lactose API USP).
LOOKING FOR A SUPPLIER?
